Rasagiline treatment for sleep disorders in Parkinson’s disease (RaSPar) – Double-blinded, randomized, placebo-controlled, placebo run-in-phase, polysomnography clinical trial
Objective: To study the effects of Rasagiline on sleep disturbances measured by polysomnographic (PSG) evaluation of sleep efficacy and secondary measures as other sleep variables,…A computerized cognitive behavioral therapy randomized, controlled, pilot trial for insomnia in Parkinson’s disease (The ACCORD-PD study)
Objective: To demonstrate benefit of computerized cognitive behavioral therapy for insomnia (CCBT-I) in Parkinson's disease (PD) patients. We are unaware of any study on CCBT-I…